Stroke public awareness campaigns have increased ambulance dispatches for stroke in Melbourne, Australia

Stroke

Volumn 42, Issue 8, 2011, Pages 2154-2157

  Bray, Janet E ^a,b,c   Mosley, Ian ^c   Bailey, Michael ^c   Barger, Bill ^a,c   Bladin, Chris ^b  

^a Blackburn North   (Australia)

^b BOX HILL HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

ambulance; diagnosis; emergency services; health education; stroke

Indexed keywords

AMBULANCE; ARTICLE; AUSTRALIA; CROSS-SECTIONAL STUDY; HEALTH CARE ACCESS; HEALTH EDUCATION; HUMAN; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SEASONAL VARIATION; SPRING; STROKE; TREND STUDY; WINTER;

AMBULANCES; AWARENESS; CROSS-SECTIONAL STUDIES; EMERGENCY MEDICAL SERVICE COMMUNICATION SYSTEMS; EMERGENCY MEDICAL SERVICES; HUMANS; RETROSPECTIVE STUDIES; STROKE; VICTORIA;

EID: 79961211224     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.612036     Document Type: Article

References (20)

1. Australian Institute of Health Welfare. Australia's Health 2008. Canberra: AIHW; 2008.
2. Senes S. How We Manage Stroke in Australia. Cat. no. CVD 31. Canberra: AIHW; 2006.
3. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
4. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-1329.
5. Deng YZ, Reeves MJ, Jacobs BS, Birbeck GL, Kothari RU, Hickenbottom SL, et al. IV tissue plasminogen activator use in acute stroke: experience from a statewide registry. Neurology. 2006;66:306-312. (Pubitemid 43739928)
6. Kleindorfer D, Kissela B, Schneider A, Woo D, Khoury J, Miller R, et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke. 2004;35:e27-e29.
7. Kwan J, Hand P, Sandercock P. A systematic review of barriers to delivery of thrombolysis for acute stroke. Age Ageing. 2004;33:116-121. (Pubitemid 38313108)
8. Handschu R, Poppe R, Rauss J, Neundorfer B, Erbguth F. Emergency calls in acute stroke. Stroke. 2003;34:1005-1009. (Pubitemid 36402979)
9. Mosley I, Nicol M, Donnan G, Patrick I, Dewey H. Stroke symptoms and the decision to call for an ambulance. Stroke. 2007;38:361-366. (Pubitemid 46184307)
10. Bray JE, O'Connell B, Gilligan A, Livingston PM, Bladin C. Is FAST stroke smart? Do the content and language used in awareness campaigns describe the experience of stroke symptoms? Int J Stroke. 2010;5: 440-446.
11. Jurkowski JM, Maniccia DM, Spicer DA, Dennison BA. Impact of a multimedia campaign to increase intention to call 9-1-1 for stroke symptoms, upstate New York, 2006-2007. Prev Chronic Dis. 2010; 7:A35.
12. Kleindorfer D, Miller R, Moomaw CJ, Alwell K, Broderick JP, Khoury J, et al. Designing a message for public education regarding stroke: does FAST capture enough stroke? Stroke. 2007;38:2864-2868. (Pubitemid 47494033)
13. Wall HK, Beagan BM, O'Neill J, Foell KM, Boddie-Willis CL. Addressing stroke signs and symptoms through public education: the Stroke Heroes Act FAST campaign. Prev Chronic Dis. 2008;5:A49.
14. Wang Y, Levi CR, Attia JR, D'Este CA, Spratt N, Fisher J. Seasonal variation in stroke in the Hunter Region, Australia: a 5-year hospital-based study, 1995-2000. Stroke. 2003;34:1144-1150. (Pubitemid 36547504)
15. Shinkawa A, Ueda K, Hasuo Y, Kiyohara Y, Fujishima M. Seasonal variation in stroke incidence in Hisayama, Japan. Stroke. 1990;21: 1262-1267. (Pubitemid 20301779)
16. Jakovljevic D, Salomaa V, Sivenius J, Tamminen M, Sarti C, Salmi K, et al. Seasonal variation in the occurrence of stroke in a Finnish adult population. The FINMONICA Stroke Register. Finnish Monitoring Trends and Determinants in Cardiovascular Disease. Stroke. 1996;27: 1774-1779. (Pubitemid 26332503)
17. Hodgson C, Lindsay P, Rubini F. Can mass media influence emergency department visits for stroke? Stroke. 2007;38:2115-2122. (Pubitemid 47012277)
18. Demaerschalk BM, Yip TR. Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States. Stroke. 2005;36:2500-2503. (Pubitemid 41566988)
19. Yip TR, Demaerschalk BM. Estimated cost savings of increased use of intravenous tissue plasminogen activator for acute ischemic stroke in Canada. Stroke. 2007;38:1952-1955. (Pubitemid 46847275)
20. Kothari R, Pancioli A, Liu T, Brott T, Broderick J. Cincinnati Prehospital Stroke Scale: reproducibility and validity. Ann Emerg Med. 1999;33: 373-378. (Pubitemid 29157560)